Pharmaceutical

The life sciences industry and regulators around the world are facing many challenges in protecting the safety of patients. Poor visibility across the supply chain has led to proliferation of drug-related criminal activities such as drug counterfeiting, illegal diversion, and theft. It has also caused inefficiencies to surface across supply chain functions. This not only hampers the brand equity of pharmaceutical companies but also puts the life of patients in serious danger. Therefore, serialization laws are fast becoming mandates in many countries.

Child-Resistant packing in Pharmaceuticals is kept aside, as most of the drugs packed in HDPE containers with CR Closure. But for few years many Innovator drug products are available in Child-Resistant design (Blister Pack) and most of them are patented or difficult to make generic due to various reasons such as Cost, Availability of supplier and manufacturing feasibility. There Packaging professional has to take a call on new design development or to use a certified pack design. But when coming to the level of protection (F Level) required for a specific drug is became a challenge, because getting Toxicology data is difficult to decide “F” Value.

To meet the regulated health care guidelines it is important for the pharma manufacturers and their packaging suppliers are aware of global standards and have the ability to verify their packaging and labelling as per globally specified standards. The methods for accurately assessing and analysing design, encodation and print quality of the barode symbols is vital to ensure smooth flow of the product along the supply chain. This ofcourse covers the family of GS1 symbologies both linear as well as 2D. The importance of a stand alone judge performing the task of barcode verification helps to identify, analyse and correct errors, in addition to keep a record of quality and compliance which is vital within the industry.